Citrullinemia: prenatal diagnosis of an affected fetus.
We monitored a pregnancy in a family at risk for citrullinemia due to argininosuccinic acid (ASA) synthetase deficiency. ASA synthetase activity in cultured epithelioid amniotic fluid cells from the fetus at risk was less than 2% of control epithelioid amniotic fluid cell activity. An increased concentration of citrulline was found in the at-risk amniotic fluid (0.14 mumol/ml) as compared with fluid from six controls and one at-risk but unaffected pregnancy (trace). The pregnancy was terminated, and the in utero diagnosis was confirmed by assay of ASA synthetase activity in cultured fetal skin fibroblasts (4.4% of control activity). In addition, all five fetal tissues studied had significant accumulation of citrulline, whereas control fetal tissues had none. These data provide evidence that, if precise control is maintained over tissue culture variables, citrullinemia can be diagnosed successfully in utero by microassay of ASA synthetase activity in cultured amniotic fluid cells. They also suggest that amniotic fluid citrulline concentrations provide strong adjunctive evidence for this prenatal diagnosis.
D000592:Amino Acid Metabolism, Inborn Errors / Q000175:diagnosis*; D000653:Amniotic Fluid / Q000032:analysis / Q000166:cytology; D001124:Argininosuccinate Synthase / Q000172:deficiency*; D002478:Cells, Cultured; D002956:Citrulline / Q000032:analysis / Q000097:blood*; D005260:Female; D006801:Humans; D008025:Ligases / Q000172:deficiency*; D011247:Pregnancy; D011296:Prenatal Diagnosis
D002956:Citrulline; D008025:Ligases; D001124:Argininosuccinate Synthase